AstraZeneca Looks To Many Modalities In Cancer
US Oncology Head Talks Strategy With Scrip
Mohit Manrao, head of AstraZeneca’s US oncology business unit, explained the company’s diverse approach in an interview, including investments in ADCs, cell therapy and radiopharmaceuticals.
